These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3052002)

  • 1. Determinants of antihypertensive response to calcium antagonists in systemic hypertension.
    Shepherd AM
    Am J Cardiol; 1988 Oct; 62(11):92G-96G. PubMed ID: 3052002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium antagonism--a new concept for treating essential hypertension.
    Müller FB; Bolli P; Erne P; Kiowski W; Bühler FR
    Am J Cardiol; 1986 Feb; 57(7):50D-53D. PubMed ID: 3006467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renin profiling to select antihypertensive baseline drugs. Renin inhibitors for high-renin and calcium entry blockers for low-renin patients.
    Bühler FR; Bolli P; Kiowski W; Erne P; Hulthén UL; Block LH
    Am J Med; 1984 Aug; 77(2A):36-42. PubMed ID: 6148011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HYT-hypertension in Turkey: a cross-sectional survey on blood pressure control with calcium channel blockers alone or combined with other antihypertensive drugs.
    Seravalle G; Koylan N; Nalbantgil I; Caglar N; Quarti-Trevano F; Makel W; Grassi G; Fici F
    High Blood Press Cardiovasc Prev; 2015 Jun; 22(2):165-72. PubMed ID: 25900022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors influencing hepatic metabolism of antihypertensive drugs: impact on clinical response.
    Höcht C; Bertera FM; Santander Plantamura Y; Parola L; Del Mauro JS; Polizio AH
    Expert Opin Drug Metab Toxicol; 2019 Jan; 15(1):1-13. PubMed ID: 30582386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age and antihypertensive response to calcium antagonists.
    Bühler FR; Kiowski W
    J Hypertens Suppl; 1987 Dec; 5(4):S111-4. PubMed ID: 3326916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium antagonists. Clinical use in the treatment of systemic hypertension.
    Spivack C; Ocken S; Frishman WH
    Drugs; 1983 Feb; 25(2):154-77. PubMed ID: 6339198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Calcium channel blockers and tissue remodeling in hypertension].
    Godfraind T
    Bull Mem Acad R Med Belg; 2001; 156(3-4):165-73; discussion 173-4. PubMed ID: 11789397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemodynamic and antihypertensive treatment responses with calcium antagonists.
    Bolli P; Kiowski W; Erne P; Hulthén LU; Bühler FR
    J Cardiovasc Pharmacol; 1985; 7 Suppl 2():S126-30. PubMed ID: 2409361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of anti-hypertensive drugs and the mechanism of hypertension in vascular smooth muscle cell-specific ATP2B1 knockout mice.
    Okuyama Y; Hirawa N; Fujita M; Fujiwara A; Ehara Y; Yatsu K; Sumida K; Kagimoto M; Katsumata M; Kobayashi Y; Saka S; Umemura S; Tamura K
    Hypertens Res; 2018 Feb; 41(2):80-87. PubMed ID: 29046519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The specificity of the hypotensive effect of calcium antagonists in hypertension].
    Ivleva AIa; Kobalava ZhD; Antiia ID; Krasnobaeva GM; Iartsev VE; Lepakhin VK; Moiseev VS
    Ter Arkh; 1991; 63(9):97-100. PubMed ID: 1759235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and pharmacological properties of calcium antagonists in essential hypertension in humans and spontaneously hypertensive rats.
    Aoki K; Kawaguchi Y; Sato K; Kondo S; Yamamoto M
    J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S298-302. PubMed ID: 6184557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The calcium antagonist isradipine and its effect on blood pressure related to plasma renin activity.
    Carr AA; Prisant LM
    Am J Hypertens; 1990 May; 3(5 Pt 1):354-9. PubMed ID: 2140943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age and pathophysiology-oriented antihypertensive response to calcium antagonists.
    Bühler FR
    J Cardiovasc Pharmacol; 1988; 12 Suppl 8():S156-66. PubMed ID: 2469897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium channel blockers in systemic hypertension.
    Frishman WH
    Am J Nephrol; 1987; 7 Suppl 1():57-66. PubMed ID: 3327382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma renin activity (PRA) levels and antihypertensive drug use in a large healthcare system.
    Sim JJ; Bhandari SK; Shi J; Kalantar-Zadeh K; Rasgon SA; Sealey JE; Laragh JH
    Am J Hypertens; 2012 Mar; 25(3):379-88. PubMed ID: 22158065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythrocyte sodium cannot predict hypotensive effects of calcium channel blockers.
    Oshima T; Matsuura H; Ozono R; Ishida-Kainouchi M; Ishida T; Ishibashi K; Watanabe M; Okura Y; Kanbe M; Kajiyama G
    Nihon Jinzo Gakkai Shi; 1993 Nov; 35(11):1227-31. PubMed ID: 8139134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Issues in drug metabolism of major antihypertensive drugs: beta-blockers, calcium channel antagonists and angiotensin receptor blockers.
    Höcht C; Bertera FM; Mayer MA; Taira CA
    Expert Opin Drug Metab Toxicol; 2010 Feb; 6(2):199-211. PubMed ID: 20095790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of aliskiren/amlodipine combination and high-dose amlodipine monotherapy on endothelial function in elderly hypertensive patients.
    Fukutomi M; Hoshide S; Mizuno H; Kario K
    Am J Hypertens; 2014 Jan; 27(1):14-20. PubMed ID: 24008122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and trends in the drug treatment of essential hypertension.
    van Zwieten PA
    J Hypertens Suppl; 1992 Dec; 10(7):S1-12. PubMed ID: 1363322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.